DEA Places Hydrocodone Products into Schedule II
The Drug Enforcement Administration moved hydrocodone combination products (HCPs) into Schedule II of the Controlled Substances Act from Schedule III. A DEA review found HCPs are "abused at high rates and have high dependence potential," it said.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 08/22/14)